Export-Only Exemption for Medical Devices in Malaysia
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The Medical Device (Exemption) Order 2024 exempts medical devices intended for export from the registration requirement. The route is relevant to manufacturers and trading entities that use Malaysia as a transhipment point or as a regional distribution base: goods that enter and leave without being placed on the domestic market can be handled under an exemption rather than under a full registration. The exemption is specific, documentary and granted per device, and it does not create a general licence to hold unregistered stock.
- The basis is an exemption order, not a guidance note. The Medical Device (Exemption) Order 2024 provides the exemption for devices for export purposes.
- Approval is evidenced by a letter. The exporter applies to the MDA and, once approved, receives a Medical Device for Export Only Exemption Letter before the goods are exported.
- Application precedes export. The submission is made before shipment, through the form channel designated by the MDA.
- One device nomenclature per application. Coverage is not portfolio-wide, so a range of products requires a series of applications.
- Export only means export only. Local sale of an exempted device still requires full registration.
- The documentation set is fixed. Company registration, the export application form, the attestation, the authorisation letter, the ISO 13485 certificate and product labelling materials.
2. Legal basis
The Medical Device (Exemption) Order 2024 exempts medical devices intended for export from the registration requirement that would otherwise apply. The scope of the exemption is defined by destination and purpose: the device must be for export, which is what allows a Malaysian entity to warehouse or consolidate products for regional supply without registering each one for the domestic market. The exemption does not disturb the other obligations that attach to the establishment, which continues to require the licence appropriate to its activity.
| Item | Requirement |
| Applicant company registration certificate | ROC of the applicant |
| Application form | Export-specific form |
| Attestation | Conformity evidence traceability declaration, on the prescribed template |
| Letter of authorisation | From OEM, contract manufacturer or authorised exporter, depending on structure |
| Quality system certificate | Copy of the manufacturer ISO 13485 certificate |
| Product materials | Datasheet, instructions for use and label, including brief description and intended use |
The application procedure is administrative but sequential. The exporter applies to the MDA, and approval is granted in the form of a Medical Device for Export Only Exemption Letter, which must be in hand before the goods are exported. The application is submitted before export through the channel designated by the MDA for that purpose. Because the letter is the evidence of exemption, the sequence cannot be reversed: goods shipped in anticipation of approval are goods shipped without the instrument that justifies their status.
The documentary requirements are set out in the MDA materials. The applicant provides its company registration certificate, the export-specific application form, an attestation covering conformity evidence traceability on the prescribed template, the letter of authorisation from the OEM, contract manufacturer or authorised exporter as the structure requires, a copy of the manufacturer ISO 13485 certificate, and the product datasheet, instructions for use and label including a brief description and the intended use. Each item answers a specific question: who is applying, what is being exported, on what conformity basis, under whose authority, under what quality system and with what labelling.
Two limits define the boundaries of the instrument. One application corresponds to one device nomenclature, so the exemption is granted product by product rather than as an organisational status. And the exemption covers the export scenario only: a device held under it cannot be placed on the Malaysian market, where full registration remains necessary. Materials are submitted according to the list current at the time of application, which means the checklist should be confirmed against the MDA list before each filing rather than reused from an earlier one.
3. Expert insights
The most common misunderstanding is that the exemption is a status rather than a permission. It is not a qualification that an entity holds; it is an approval that attaches to a named device for an export purpose. An organisation that treats the first approval as evidence of a general capability will file nothing further and then ship a different product under a letter that does not cover it. Because the letter names the device, the gap is visible on the face of the documents.
The second misunderstanding concerns the boundary with the domestic market. Export-only goods are exempt because they leave; the moment a unit is sold locally, the exemption no longer describes the transaction and the device requires registration. This is not a technicality that can be managed through documentation, because the underlying regulatory position is that the domestic market is closed to unregistered devices.
The third issue is documentary consistency, and it is the one that most often delays a filing. The ISO 13485 certificate has a holder, the letter of authorisation has a grantor, and the applicant has a corporate identity. Where the certificate is held by one entity, the authorisation is granted by another and the applicant is a third, the chain must be explained rather than assumed. Reviewers read the documents as a set, and an unexplained gap between the certificate holder and the authorisation chain is a gap in the conformity basis.
4. Practical recommendations
- Plan the exemption alongside the EL and the import permit regime on a single compliance map. The three instruments cover different scenarios and are frequently conflated, which produces filings under the wrong route.
- List every device nomenclature intended for export and file one application per nomenclature, rather than assuming that a product family is covered as a whole.
- Confirm the current documentary list with the MDA before each filing, since materials are submitted according to the list in force at the time.
- Check the consistency of the ISO 13485 certificate holder, the party granting authorisation and the applicant, and explain any difference in the file rather than leaving it to inference.
- Keep export-only stock physically and documentary separate from domestic stock, so that the exemption status of each unit is demonstrable.
- Obtain the exemption letter before shipment, and treat the letter as a shipping document rather than as an archive item.
5. Verification checklist
- □ Confirm the scope of the Medical Device (Exemption) Order 2024.
- □ Confirm the application requirements in the Medical Device for the Purpose of Export Only section of the MDA website, including the application materials table.
- □ Confirm the attestation template and the letter of authorisation requirement for the intended structure.
- □ Confirm that the ISO 13485 certificate on file matches the manufacturing entity named in the application.
- □ Confirm that no unit covered by the exemption is intended for local sale.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Malaysia. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the MDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us